In a co-primary endpoint, following the lead-in period, participants taking tirzepatide achieved an additional 21.1% mean weight loss
Why Choose Begin Anew Benefits of a Medical Weight Management Program at Begin Anew Our medical weight management programs are designed to provide structured, medically supervised support tailored to your individual health profile
Dickson SP, Wessels AM, Dowsett SA, Mallinckrodt C, Sparks JD, Chatterjee S, et al
The primary outcome measure is time to first major cardiovascular event over five years of follow-up
Informe a su mdico acerca del resto de medicamentos que est utilizando, especialmente insulina u otros medicamento para la diabetes como dulaglutide, exenatide, liraglutide, Byetta, Trulicity, Victoza, y otros